• SENSEX 73,895.74
    315.20 (+0.43%)
  • BANKNIFTY 55,580.40
    141.90 (+0.26%)
  • ICICI Bank
    1,311.70 1,187.55(%)
  • NSE
    1,790.00 1,790.00(%)
  • SS Retail
    692.30 603.00(%)
  • PB Fintech.
    1,115.10 1,115.10(%)
  • The Bombay Burmah
    1,425.75 1,301.00(%)
  • Hero Motors
    141.85 141.85(%)
  • Whirlpool India
    959.60 1,438.30(%)
  • Cholaman.Inv.&Fn
    1,638.05 1,299.80(%)
  • Larsen & Toubro
    3,885.90 4,440.00(%)
  • Tour. Fin. Corp.
    135.55 51.20(%)
  • Kotak Mah. Bank
    399.35 345.40(%)
  • AU Small Finance
    1,021.20 1,144.65(%)
  • Infosys
    991.75 984.00(%)
  • Rainbow Child.
    1,351.50 1,008.75(%)
  • Kaveri Seed Co.
    844.00 1,139.90(%)
  • Cupid
    274.15 298.95(%)
  • Reliance Industries
    1,227.20 1,611.20(%)
  • HDFC Bank
    739.50 1,020.35(%)
  • Shanti Gold
    333.00 333.00(%)
  • Tata Consumer
    979.10 979.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

MPS Pharmaa Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 14103.0
  • ISIN : INE537C01019
2.08 0 (0.00%)
  • As on 27 Sep 2026 (EOD)

  • Today’s Low

    2.08

  • Today’s High

    2.08

  • Open

    2.08

  • Perv Close

    2.08

  • 52W Low

    1.57

  • 52W High

    2.08

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    3.98

  • Div & Yield %

    0.00

  • Book Value(₹)

    0.04

  • Debt-Equity Ratio

    0.00

  • AGM Date

    21-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    3.98

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    19.11

  • BV (₹)

    0.00

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -1.02

  • NP Var(%)

    -14.0

  • Div%

    0.0

  • CPS (₹)

    -0.50

  • EPS (₹)

    -0.50

  • Traded Value (₹ in Lakhs)

    3.98

  • 52 Week High

    2.08

  • 52 Week Low

    1.57

  • Price BSE

    2.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    3.98

  • P/C Ratio

    -4.40

  • P/E Ratio

    -3.70

  • Price Vs.BV

    -0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.03 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.03 0.00
Other Income 0.04 0.05 0.09 0.02 0.26 0.20
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.04 0.05 0.09 0.02 0.29 0.20
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.04 0.05 0.00
Power and Fuel Cost 0.06 0.05 0.05 0.05 0.05 0.06
Employee Cost 0.53 0.52 0.53 0.49 0.42 0.40
Other Manufacturing Expenses 0.01 0.02 0.03 0.16 0.01 0.00
Selling and Administration Expenses 0.18 0.17 0.18 0.19 0.17 0.17
Miscellaneous Expenses 0.16 0.00 0.02 0.01 0.00 3.49
Employee Benefit Expenses 0.53 0.52 0.53 0.49 0.42 0.40
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.94 0.76 0.80 0.94 0.70 4.13
Operating Profit -0.91 -0.72 -0.71 -0.93 -0.42 -3.94
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit -0.91 -0.72 -0.71 -0.93 -0.42 -3.94
Depreciation 0.15 0.15 0.15 0.15 0.51 0.56
Profit Before Tax -1.06 -0.87 -0.86 -1.08 -0.93 -4.50
Current Tax 0.00 0.03 0.00 0.00 -0.36 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.04 0.00 -0.02 -0.02 -0.43 -0.08
Reported Net Profit -1.02 -0.90 -0.83 -1.05 -0.14 -4.42
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.18
Adjusted Net Profit -1.02 -0.90 -0.83 -1.05 -0.14 -4.60
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -18.13 -17.24 -16.41 -15.36 -15.21 -10.80
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -19.15 -18.13 -17.24 -16.41 -15.36 -15.21
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.53 -0.47 -0.43 -0.55 -0.07 -2.31
Earnings Per Share(Adj)-Unit Curr -0.53 -0.47 -0.43 -0.55 -0.07 -2.31
Book Value 0.04 0.57 1.03 1.46 2.00 2.07
Book Value(Adj)-Unit Curr 0.04 0.57 1.03 1.46 2.00 2.07

Shareholding Pattern

  • Promoter Group

    35.89%

  • Public Share Holding

    64.11%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,902,322 25.65 4,902,322 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,957,159 10.24 1,957,159 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,859,481 35.89 6,859,481 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 110,280 0.58 110,280 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 110,280 0.58 110,280 1
2] Non Institution
Bodies Corporate 4,860,218 25.43 4,860,218 42
Clearing Members 5,336 0.03 5,336 6
Directors of their Relatives 10 0.00 10 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 24,575 0.13 24,575 29
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,543,900 18.54 3,543,900 36
Individuals holding nominal share capital up to Rs. 1 lakh 3,707,150 19.40 3,695,935 4,291
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 450 0.00 450 1
Sub Total 12,141,639 63.53 12,130,424 4,406
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 19,111,400 100.00 19,100,185 4,409

Company Background

MPS Pharmaa LtdPharmaceuticals - Indian - Formulations

  • MPS Pharmaa Ltd
  • BSE Code : 14103.0
  • ISIN : INE537C01019

  • Incorporation Year

    1994

  • Registered Office

    138 Roz-Ka-Meo Industrial Area
    Sohna, Mewat,
    Haryana-122103

  • Telephone

    91-124-2362471/2014471

  • FAX

  • Chairman

    Peeyush Kumar Aggarwal

  • Managing Director

  • Company Secretary

    Pooja Chuni

  • Auditor

    Nemani Garg Agarwal & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.&Computer Ser.P Ltd
    99 BeetalHouse 3rd F,
    Behind Local Shp Cen,Nr Dada Harsukh Das
    Mumbai - New Delhi - 110062

MPS Pharmaa Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 26,935.80 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 6,517.85 2,304.07 2,275.58 96.06 27.86
Glaxosmi. Pharma 2,816.85 3,932.76 3,790.20 45.00 58.17
Novartis India 1,961.40 393.10 354.33 49.53 15.94
Cipla 1,397.20 20,102.60 18,979.95 36.72 13.88
Bliss GVS Pharma 709.30 773.53 729.81 65.92 12.51
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Fermenta Biotec. 468.15 474.15 450.25 21.86 18.77
Guj. Themis Bio. 417.30 168.25 165.82 111.58 18.05
Ambalal Sarabhai 40.55 19.52 3.94 75.09 6.77